catechin has been researched along with amphotericin b in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Cho, SJ; Park, KD | 1 |
Jin, YS | 1 |
Hirasawa, M; Takada, K | 1 |
Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K | 1 |
Han, Y | 1 |
Ling, J; Ning, Y; Wu, CD | 1 |
Ghosh, D; Jha, NN; Kumar, A; Kumar, R; Maji, SK; Mondal, M; Navalkar, A; Panigrahi, R; Sahay, S | 1 |
1 review(s) available for catechin and amphotericin b
Article | Year |
---|---|
Recent advances in natural antifungal flavonoids and their derivatives.
Topics: Antifungal Agents; Biological Products; Flavonoids; Fungi; Humans; Mycoses | 2019 |
8 other study(ies) available for catechin and amphotericin b
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
Topics: Anti-Infective Agents; Bacteria; Camellia sinensis; Catechin; Drug Design; Drug Stability; Fungi; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Molecular Structure; Tea | 2010 |
Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Catechin; Colony Count, Microbial; Culture Media; Drug Synergism; Hydrogen-Ion Concentration; Microbial Sensitivity Tests | 2004 |
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity | 2006 |
Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Catechin; Drug Synergism; Female; Hyphae; Mice; Mice, Inbred BALB C | 2007 |
Synergistic effects of tea catechin epigallocatechin gallate and antimycotics against oral Candida species.
Topics: Amphotericin B; Anilides; Antifungal Agents; Biofilms; Candida; Catechin; Drug Synergism; Fluconazole; Miconazole; Microbial Sensitivity Tests; Polyphenols; Tetrazolium Salts | 2015 |
Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors.
Topics: alpha-Synuclein; Amphotericin B; Amyloid; Binding Sites; Catechin; Dopamine; Kinetics; Neuroprotective Agents; Protein Binding | 2017 |